Analystreport

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is now covered by analysts at Goldman Sachs Group Inc. They set a "sell" rating on the stock.

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com